These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35173731)

  • 1. Identifying COVID-19 Infections From a Vaccinated Population Using Specific IgA Antibody Test.
    Cheng ZJ; Zheng P; Xue M; Chen Y; Sun B
    Front Immunol; 2022; 13():821218. PubMed ID: 35173731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
    Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
    Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients.
    Kurano M; Ohmiya H; Kishi Y; Okada J; Nakano Y; Yokoyama R; Qian C; Xia F; He F; Zheng L; Yu Y; Jubishi D; Okamoto K; Moriya K; Kodama T; Yatomi Y
    Front Immunol; 2022; 13():811952. PubMed ID: 35126396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
    Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
    J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
    Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
    PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2.
    Furuya AKM; Wagner C; Connors J; Bodnar J; Miller T; Ryman NL; Warszycki CJ; Wong SJ; Walsh AC; McDonough KA; Lee WT
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115298. PubMed ID: 33418405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM.
    Wang P
    Pol J Microbiol; 2024 Jun; 73(2):123-130. PubMed ID: 38905276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.
    Ma H; Zhao D; Zeng W; Yang Y; Hu X; Zhou P; Weng J; Cheng L; Zheng X; Jin T
    Sci China Life Sci; 2021 Mar; 64(3):482-485. PubMed ID: 32876887
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Chen M; Qin R; Jiang M; Yang Z; Wen W; Li J
    Int J Infect Dis; 2021 Mar; 104():415-422. PubMed ID: 33450372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers.
    Hasan T; Lim HL; Hueston L; Dwyer DE; O'Sullivan M
    Pathology; 2021 Dec; 53(7):917-919. PubMed ID: 34635322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.